|
Pilot study examining the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among MMT patients. - 2 Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on Pilot study examining the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among MMT patients. - 2 conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Pilot study examining the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among MMT patients. - 2 Clinical research trials and Pilot study examining the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among MMT patients. - 2 health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Pilot study examining the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among MMT patients. - 2. Pilot study examining the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among MMT patients. - 2 Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Pilot study examining the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among MMT patients. - 2 clinical trial. Participants oftentimes recieve the most expert healthcare available for their Pilot study examining the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among MMT patients. - 2 condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Pilot study examining the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among MMT patients. - 2  Pilot study examining the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among MMT patients. - 2
Pilot study examining the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among MMT patients. - 2
For Condition: Tobacco Use Disorder
Status: Recruiting
Sponsor(s): National Institute on Drug Abuse (NIDA) ,
Synopsis: Pilot study examining the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among MMT patients.
Details: This is a one-arm, open label pilot study of MMT patients to determine whether bupropion, nicotine replacement therapy, and behavioral counseling is a feasible and potentially effective intervention for smoking cessation. The smoking behaviors fo participants will be be followed for 6 months post quit-date to determine effect-size estimates for a future, large scale trial.
Eligibility:
Study Type: Interventional, Treatment, Open Label, Uncontrolled
Minimum Age/Maximum Age: 18 Years/70 Years
Genders: Both
Protocol Entry Criteria: Please contact site for information Inclusion Criteria: 30 patients in long-term methadone maintenance treatment. Each smoke at least 10 cigarettes per day, are stable on their use of methadone (phase 2 or higher treatment), smoked for at least 1 year, be willing to participate for 6 months, and not have used bupropion or nicotine replacement therapy for 6 months. Exclusion Criteria: a) Patients who use prescription drug regimens that might affect methadone or bupropion metabolism, b) patients with cardiovascular disease, asthma, COPD, c) pregnant or breastfeeding, d) patients with regular use of alcohol, other illicit drugs, or other types of tobacco (chewing or pipe for example).
Total Enrollment: 34
Location and Contact Information:
Overall Study Official:
KimberRichter, Principal Investigator, University of Kansas
University of Kansas Medical Center *Recruiting*
Kansas City, Kansas, 66160 7420
United States
Recruiting Robert Mccool 913-588-2502
Additional Information:
Study ID Numbers: NIDA-00450-2; K01-00450-2
Study Start Date: September 2002
Record last reviewed: September 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00060814
Other Tobacco Use Disorder Studies:
1. Effects of Labetalol on Nicotine Administration in Humans - 14
2. Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
3. Bupropion and Weight Control for Smoking Cessation - 1
4. Role of Metabolites in Nicotine Dependence (3) - 6
5. Maintenance treatment for Prevention of Smoking Relapse - 1
Related Studies:
Other Tobacco Use Disorder Clinical Trials
Other Kansas Clinical Trials
Other Kansas City Clinical Trials
Pilot study examining the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among MMT patients. - 2
|
|
|
|
|
|
|
|
